Evaluation of Neo-angiogenesis in a Case of Chordoid Meningioma
Overview
Authors
Affiliations
Chordoid is a rare variant of meningioma that displays a high recurrence rate. In this study we evaluated the immunohistochemical expression of factors that regulate the neo-angiogenesis process in a case of chordoid meningioma with an adverse clinical course. A high microvessel density (MVD), as well as high VEGF and VEGF-R1 expression, was encountered in this tumor. By contrast, the anti-angiogenic factor semaphorin3A, highly expressed in this chordoid meningioma, was ineffective because of the absence of its receptor neuropilin-1. We suggest that VEGF expression and MVD may represent significant prognostic factors in chordoid meningiomas.
Franke A, Skelton Iv W, Woody L, Bregy A, Shah A, Vakharia K Surg Neurol Int. 2018; 9:133.
PMID: 30090665 PMC: 6057170. DOI: 10.4103/sni.sni_264_17.
Granata F, Morabito R, Alafaci C, Barresi V, Tomasello F, Vinci S Neuroradiol J. 2015; 28(3):303-9.
PMID: 26246100 PMC: 4757289. DOI: 10.1177/1971400915592551.
Chordoid meningioma: a retrospective series of seven consecutive cases.
Passacantilli E, Lapadula G, Caporlingua F, Lenzi J, Antonelli M, Santoro F Neurol Sci. 2013; 34(11):1985-9.
PMID: 23595544 DOI: 10.1007/s10072-013-1431-8.
Bevacizumab therapy for adults with recurrent/progressive meningioma: a retrospective series.
Lou E, Sumrall A, Turner S, Peters K, Desjardins A, Vredenburgh J J Neurooncol. 2012; 109(1):63-70.
PMID: 22535433 PMC: 3404217. DOI: 10.1007/s11060-012-0861-0.
Chordoid meningioma in a patient with lymphangioleiomyomatosis.
Campos-Franco J, Otero E, Lopez-Garcia E, Abdulkader I, Gonzalez-Quintela A J Neurooncol. 2011; 105(3):667-9.
PMID: 21643986 DOI: 10.1007/s11060-011-0622-5.